Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "Life-Science"

523 News Found

Vakrangee to distribute Corival products
Supply Chain | November 15, 2021

Vakrangee to distribute Corival products

Vakrangee’s distribution network across rural India will help penetrate underserved markets


Thermo Fisher to set up manufacturing facility in Mebane N.C.
Medical Device | November 13, 2021

Thermo Fisher to set up manufacturing facility in Mebane N.C.

The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics


Laurus Labs PAT at Rs 201.90 cr. in Q2FY21
News | October 29, 2021

Laurus Labs PAT at Rs 201.90 cr. in Q2FY21

Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021


Merck expands capacity for Antibody Drug Conjugate (ADC), therapies
Biotech | October 29, 2021

Merck expands capacity for Antibody Drug Conjugate (ADC), therapies

Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges


Transforming Healthcare Through AI
Opinion | October 29, 2021

Transforming Healthcare Through AI


Thermo Fisher Scientific unveils Q Digital PCR system
Medical Device | October 28, 2021

Thermo Fisher Scientific unveils Q Digital PCR system

It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development


10x Genomics opens Singapore manufacturing hub
Biotech | October 26, 2021

10x Genomics opens Singapore manufacturing hub

Strengthens supply chain continuity with first manufacturing facility outside of the U.S.


Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22
News | October 25, 2021

Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22

The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively


Biocon Q2FY22 in line with estimates, better margins: ICICI Direct
News | October 25, 2021

Biocon Q2FY22 in line with estimates, better margins: ICICI Direct

Key takeaways of recent quarter & conference call highlights


Boehringer Ingelheim and partners to develop gene therapy for patients with cystic fibrosis
Biotech | October 21, 2021

Boehringer Ingelheim and partners to develop gene therapy for patients with cystic fibrosis

It has exercised intellectual property options from IP Group regarding research results generated by the UK Cystic Fibrosis Gene Therapy Consortium, and from Oxford Biomedica regarding their lentiviral vector technology